Loading...
This record has been deleted. Since it is linked to a published record, it is available here for reference purposes only.
Click here to view the deleted recordThis document has been updated. This is not the latest published version. Click here to view the latest version of the record.
Internationally Recognized Certificates of Compliance
(IRCC)
last updated: 13 Aug 2018
ABSCH-IRCC-IN-240676-1
Competent National Authority:National Biodiversity Authority ()5th Floor, TICEL Biopark, CSIR Road, TaramaniChennai, Tamilnadu
600 113, IndiaPhone: +91 44 2254 2777,Fax: +91 44 2254 1200,Website: http://www.nbaindia.org,
India/NBA/Appl/9/706
Application in Form-III for seeking approval for the invention “Compositions comprising probiotic Lactobacillus strains for improved vaginal health” for obtaining IP Rights in India.
Patent Application Number: 3759/DEL/2011
06 Feb 2016
Yes
Competent National Authority:National Biodiversity Authority ()5th Floor, TICEL Biopark, CSIR Road, TaramaniChennai, Tamilnadu
600 113, IndiaPhone: +91 44 2254 2777,Fax: +91 44 2254 1200,Website: http://www.nbaindia.org,
Confidential information
Organization:M/s. Talwar Research Foundation (TRF)Academic or research instituteE- 8, Neb Valley, Neb Sarai,New Delhi, New Delhi
110 068, IndiaPhone: +91 11 29536769,Fax:Website:
Confidential information
Yes
1. The user shall notify the NBA within 30 days from the date of grant of IPR .
2. If the user himself commercializes the process/product/innovation, the monetary sharing shall be 0.2% on the annual gross ex-factory sale minus
government taxes.
government taxes.
3. The user needs to inform the NBA about any commercialization made on the IP Rights granted.
4. The user shall submit half-yearly report to NBA as per the terms and conditions agreed upon.
For obtaining IP Rights on the Invention ““Compositions comprising probiotic Lactobacillus strains for improved vaginal health” in India
Biological Resources:
1. Lactobacillus fermentum ssp., mucosae
2. Lactobacillus gasseri
3. Lactobacillus salivarius
4. Curcumin/Diferuloylmethane
5. Emblica officinalis
6. Azadirachta indica- leaves
7. Aloe vera
8. Sapindus mukorossi
9. Hydrosol portion of the distillate of rose (Rosa) petals (Rose water)
Confidential information
- Commercial
1. If the user assigns/licenses the process/product/innovation to a third party for commercialization, the user shall pay to NBA 3.0% of the fee received (in any form including the license / assignee fee) and 2.0% of the royalty amount received annually from the assignee/licensee.
2. In case the user assigns or transfer the IPR in whole or in part to any person, whether voluntarily or involuntarily, the user undertakes to attach this agreement as an appendix to the assignment instrument which shall be binding upon such person.
| Unique identifier | Status | Date |
|---|---|---|
| ABSCH-IRCC-IN-240676-1 |
REVOKED
OLD VERSION
PUBLISHED
DELETED
|
Sujata Arora (sujata@nic.in)
13 Aug 2018 05:31 on 13 Aug 2018 05:31
|
